HDFC Mutual Fund Increases Stake in Global Health with ₹130 Crore Deal
HDFC Mutual Fund has significantly bolstered its position in Global Health, the parent company of the renowned Medanta hospital chain, through a fresh block deal. This latest acquisition underscores the growing institutional confidence in the healthcare sector's long-term growth trajectory.
Massive Stake Acquisition via Open Market
In a significant move on Thursday, HDFC Mutual Fund acquired an additional 10 lakh shares of Global Health through open market transactions. The deal was executed at an average price of ₹1,300 per share, bringing the total transaction value to ₹130 crore. This purchase represents a 0.37 per cent stake in the company.
The shares were offloaded by Sunil Sachdeva, a co-founder of Medanta Hospitals. This transaction follows a similar pattern from last month, where HDFC Mutual Fund had already purchased 10 lakh shares from Sachdeva for a consideration of over ₹122 crore. At the close of the March quarter, Sachdeva held 2.90 crore equity shares, representing a 10.79 per cent stake in the healthcare major.
Robust Financial Performance Drives Investor Interest
The aggressive accumulation of shares by HDFC Mutual Fund comes on the heels of stellar financial results reported by Global Health. The company has demonstrated impressive top-line and bottom-line growth, signaling strong operational efficiency in its hospital network.
For the fourth quarter ended March 31, 2026, Global Health reported a massive 39.7 per cent surge in Profit After Tax (PAT), reaching ₹141.7 crore. This is a significant jump from the ₹101.4 crore PAT recorded in the same quarter of the previous fiscal year. Furthermore, the company's revenue from operations saw a substantial climb to ₹1,159 crore, compared to ₹931.3 crore in the year-ago period.
Market Reaction and Sector Outlook
Despite the positive news regarding institutional buying, the stock witnessed minor volatility. Shares of Global Health slipped 0.41 per cent on the BSE, closing at ₹1,311.35. However, the continuous buying interest from large-scale institutional investors like HDFC Mutual Fund suggests that the market perceives the current valuation as attractive given the company's growth momentum.
As the healthcare industry in India continues to expand due to rising medical demand and infrastructure development, companies with established brands like Medanta are positioned as key beneficiaries. The strategic movement by HDFC MF highlights how institutional capital is rotating into high-growth, high-margin healthcare services.
Key Takeaways
- Strategic Accumulation: HDFC Mutual Fund acquired 10 lakh additional shares of Global Health at ₹1,300 per share, totaling a ₹130 crore investment.
- Strong Financial Growth: Global Health reported a 39.7% increase in PAT to ₹141.7 crore and a significant rise in quarterly revenue to ₹1,159 crore.
- Institutional Confidence: This follows a previous acquisition of 10 lakh shares last month, indicating a sustained interest in the Medanta-run healthcare chain.